A retrospective study of the management of retro-peritoneal bleeding after percutaneous coronary intervention in the era of combination anti-platelet therapy
Author:
- 1 January 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Medicine
- Vol. 9 (1) , 56-58
Abstract
Combination anti-platelet therapy is mandatory in patients undergoing percutaneous coronary intervention (PCI) to reduce coronary events and stent thrombosis but increases the risk of bleeding. In particular, the management of retroperitoneal haemorrhage (RPH) after PCI is uncertain and made more complex as multiple anti-platelet agents are given routinely. We audited the outcome of patients who experienced RPH and sought to determine whether operative management was required. We conducted a retrospective observational audit of all patients undergoing PCI at a single institution over a 5-year period. RPH occurred in 12 patients. Nine patients were managed without surgery. Patients with RPH needed prolonged admissions (mean length of stay 9.5 days), and were transfused with a mean of 4.5 units of packed red cells. Although there were no deaths, one patient had a spinal infarction. Management of RPH may be conservative unless there is ongoing bleeding. RPH has resource implications in terms of transfusions, prolonged length of stay and morbidity.Keywords
This publication has 10 references indexed in Scilit:
- An unusual cause of shock after cardiac catheterizationCanadian Journal of Emergency Medicine, 2005
- Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devicesJACC, 2005
- Bradycardia in acute haemorrhageBMJ, 2004
- Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatmentHeart, 2003
- Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet actionJournal of Vascular Surgery, 2002
- Death during percutaneous transluminal coronary angioplasty (PTCA) and the medicolegal aspectsForensic Science International, 1999
- Randomized, Placebo-Controlled Trial of Platelet Glycoprotein IIb/IIIa Blockade With Primary Angioplasty for Acute Myocardial InfarctionCirculation, 1998
- Retroperitoneal haemorrhage: A dangerous complication of common femoral arterial punctureEuropean Journal of Vascular Surgery, 1993
- Vascular Complications of Percutaneous Femoral Cardiac InterventionsArchives of Surgery, 1988
- CT evaluation of retroperitoneal hemorrhage associated with femoral arteriographyAmerican Journal of Roentgenology, 1986